Discontinuation from Collagenase Clostridium histolyticum Therapy for Peyronie's Disease: Review and Single-Center Cohort Analysis.
Amighi A, Eleswarapu SV, Mendhiratta N, Nork JJ, Mills JN.
Amighi A, et al. Among authors: eleswarapu sv.
Sex Med Rev. 2019 Oct;7(4):690-698. doi: 10.1016/j.sxmr.2019.05.001. Epub 2019 Jun 10.
Sex Med Rev. 2019.
PMID: 31196763
Review.
Counseling to reduce CCh discontinuation should focus on initial sexual function, adverse events, and expectations. Amighi A, Eleswarapu SV, Mendhiratta N, et al. Discontinuation from Collagenase Clostridium histolyticum Therapy for Peyronie's Disease: Review and Si …
Counseling to reduce CCh discontinuation should focus on initial sexual function, adverse events, and expectations. Amighi A, Eleswarapu …